Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.6150
+0.0070 (1.15%)
At close: Mar 19, 2026, 4:00 PM EDT
0.5860
-0.0290 (-4.72%)
Pre-market: Mar 20, 2026, 8:05 AM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $12.81 million as of March 20, 2026. Its market cap has decreased by -15.03% in one year.
Market Cap
12.81M
Enterprise Value
7.23M
1-Year Change
-15.03%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $12.81M, a decrease of -61.65%. That is a compound annual growth rate of -47.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 12.66M | -14.37% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 13.29M |
| Quoin Pharmaceuticals | 13.07M |
| CalciMedica | 13.03M |
| Soligenix | 12.71M |
| Purple Biotech | 12.67M |
| CytoMed Therapeutics | 12.35M |
| IO Biotech | 12.02M |
| NewcelX | 11.99M |